recent
new
type
coronaviru
identifi
name
novel
coronaviru
world
health
organ
caus
increas
rate
pneumonia
case
sinc
late
decemb
infect
first
identifi
wuhan
china
detect
chines
citi
dozen
countri
around
world
earli
februari
outbreak
declar
public
health
emerg
intern
concern
januari
pneumonia
character
flulik
symptom
includ
fever
cough
sever
acut
respiratori
distress
syndrom
case
death
humantohuman
transmiss
confirm
viru
consid
relat
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
like
sarscov
merscov
seriou
threat
human
health
march
nearli
peopl
diagnos
world
effect
prevent
treatment
crucial
situat
tradit
chines
herbal
medicin
therapi
mixtur
chines
herb
prescrib
chines
herbalist
depend
differenti
patient
syndrom
accord
chines
diagnost
pattern
inspect
listen
smell
inquiri
palpat
studi
report
chines
herbal
formula
san
wu
huangqin
decoct
lianhuaqingwen
capsul
yinhuapinggan
granul
possess
antivir
effect
might
associ
block
prolifer
replic
viral
particl
might
abl
improv
lung
damag
influenza
virus
sar
epidem
tradit
chines
herbal
medicin
treatment
report
success
prevent
treat
sar
furthermor
tradit
chines
herbal
medicin
combin
western
medicin
treatment
regimen
reduc
advers
event
complic
induc
glucocorticoid
antibiot
antivir
treatment
pneumonia
outbreak
state
administr
tradit
chines
medicin
china
led
expert
team
formul
tradit
chines
herbal
medicin
treatment
program
januari
first
case
cure
patient
beij
discharg
hospit
tradit
chines
herbal
medicin
treatment
symptomat
therapi
report
later
anoth
cure
patient
report
follow
tradit
chines
herbal
medicin
therapi
prompt
wider
applic
tradit
chines
herbal
medicin
patient
pneumonia
januari
gener
offic
nation
health
health
commiss
china
offic
state
administr
tradit
chines
medicin
issu
diagnosi
treatment
pneumonia
caus
novel
coronaviru
infect
trial
version
includ
updat
tradit
chines
herbal
medicin
treatment
program
requir
local
health
health
committe
implement
strengthen
integr
tradit
chines
herbal
medicin
western
medicin
although
tradit
chines
herbal
medicin
treatment
appli
pneumonia
uncertainti
remain
effect
therefor
intend
systemat
review
studi
applic
tradit
chines
herbal
medicin
patient
order
examin
empir
evid
effect
tradit
chines
herbal
medicin
pneumonia
aim
provid
robust
evid
base
clinic
practic
treat
pneumonia
systemat
review
regist
prospero
februari
prepar
protocol
accord
prefer
report
item
systemat
review
metaanalysi
prismap
statement
addit
file
updat
prospero
record
import
amend
random
trial
quasirandom
prospect
control
clinic
trial
test
tradit
chines
herbal
medicin
without
western
medicin
includ
restrict
blind
followup
public
statu
public
english
chines
includ
patient
diagnos
pneumonia
caus
without
immedi
lifethreaten
comorbid
includ
restrict
respect
gender
age
ethnic
tradit
chines
herbal
medicin
involv
extract
herb
singl
mixtur
herbal
formula
regardless
composit
form
tradit
chines
herbal
medicin
combin
one
pharmacolog
intervent
also
includ
restrict
respect
dosag
frequenc
durat
followup
time
treatment
restrict
respect
type
compar
compar
like
includ
western
medic
therapi
support
care
therapeut
method
primari
outcom
surviv
end
treatment
end
followup
time
rate
patient
becom
neg
also
assess
follow
outcom
end
treatment
end
followup
day
absenc
fever
symptom
score
base
fever
fatigu
cough
difficulti
breath
poor
appetit
etc
durat
symptom
pulmonari
function
inflamm
index
result
chest
computer
tomographi
length
stay
hospit
use
includ
dosag
durat
corticosteroid
qualiti
life
advers
event
outcom
report
elig
studi
extract
report
give
particular
attent
possibl
select
report
bia
use
outcom
review
exclus
criteria
follow
patient
lifethreaten
comorbid
like
lead
death
within
trial
followup
period
duplic
data
data
extract
contact
origin
author
full
text
obtain
contact
origin
author
search
electron
databas
includ
pubm
embas
cochran
central
regist
control
trial
central
chines
biomed
literatur
databas
cbm
china
nation
knowledg
infrastructur
cnki
chines
scienc
technolog
period
databas
vip
wanfang
databas
wanfang
data
use
keyword
combin
novel
coronaviru
pneumonia
tradit
chines
herbal
medicin
chines
herb
tradit
chines
medicin
full
search
strategi
pubm
provid
addit
file
similar
strategi
appli
electron
databas
refer
list
relev
trial
review
search
manual
search
gray
literatur
confer
proceed
academ
degre
dissert
trial
registri
intern
clinic
trial
registri
platform
icrp
websit
nation
registri
consult
expert
field
possibl
studi
includ
export
identifi
record
databas
endnot
softwar
use
identifi
duplic
remov
duplic
retriev
record
check
independ
two
review
xl
dz
appli
elig
criteria
base
titl
abstract
studi
potenti
elig
full
text
obtain
check
independ
two
review
xl
dz
identifi
elig
studi
disagr
discuss
resolv
discuss
third
review
jl
order
achiev
consist
least
extract
item
data
extractor
extract
data
sampl
elig
studi
result
pilot
extract
discuss
among
review
author
extractor
two
independ
review
yl
lg
extract
data
predefin
extract
templat
includ
follow
item
gener
author
titl
journal
year
public
countri
fund
sourc
studi
design
etc
characterist
gender
stage
sever
diseas
syndrom
differenti
comorbid
etc
characterist
chines
herbal
medicin
type
dosag
frequenc
durat
etc
protocol
compar
type
dosag
frequenc
durat
etc
characterist
set
ambulatori
sectorhospit
sampl
size
number
recruit
random
alloc
intervent
anoth
method
follow
analyz
gener
random
sequenc
alloc
conceal
blind
studi
length
followup
etc
outcom
main
conclus
advers
event
etc
origin
author
contact
request
miss
data
necessari
extract
inform
crosscheck
yl
lg
disagr
discuss
resolv
discuss
third
review
yz
order
achiev
consist
least
risk
bia
assess
risk
bia
assessor
preassess
sampl
elig
studi
result
pilot
risk
bia
discuss
among
review
author
assessor
two
independ
review
yl
dz
assess
risk
bia
includ
studi
studi
level
follow
guidanc
latest
version
cochran
handbook
systemat
review
intervent
choos
use
tool
assess
risk
bia
random
trial
version
cochran
riskofbia
tool
random
trial
rob
nonrandom
trial
risk
bia
nonrandom
studi
intervent
robinsi
tool
disagr
discuss
resolv
discuss
third
review
rj
studi
high
risk
bia
unclear
bia
given
less
weight
data
synthesi
statist
analys
conduct
use
revman
softwar
version
r
softwar
version
possibl
analys
outcom
done
intent
treat
perform
analys
provid
effect
estim
dichotom
data
continu
data
confid
interv
use
risk
ratio
rr
dichotom
data
mean
differ
md
continu
data
explor
heterogen
perform
metaanalysi
outcom
heterogen
detect
use
standard
chisquar
test
signific
level
p
statist
appli
quantifi
inconsist
across
studi
assess
impact
heterogen
metaanalys
mantelhaenszel
method
use
dichotom
outcom
dersimonian
laird
invers
varianc
method
use
continu
outcom
randomeffect
model
use
pool
data
adequ
number
studi
identifi
perform
subgroup
analysi
follow
variabl
age
patient
without
diseas
stage
tradit
chines
herbal
medicin
given
also
consid
analys
subgroup
report
includ
studi
give
particular
attent
possibl
select
report
bia
use
subgroup
review
trial
sequenti
analysi
provid
necessari
sampl
size
metaanalysi
boundari
determin
whether
evid
metaanalysi
reliabl
conclus
perform
trial
sequenti
analysi
maintain
overal
risk
type
error
calcul
requir
sampl
size
check
robust
pool
outcom
result
carri
sensit
analysi
explor
influenc
studi
high
risk
bia
suffici
number
articl
includ
assess
small
studi
bias
eg
public
bia
funnel
plot
egger
test
begg
test
trim
fill
analysi
two
independ
review
dlz
jl
assess
qualiti
evid
outcom
grade
recommend
assess
develop
evalu
grade
system
outcom
assess
five
aspect
limit
inconsist
indirect
imprecis
public
bia
rate
high
moder
low
low
level
like
outbreak
caus
sar
mer
recent
outbreak
china
creat
substanti
public
health
challeng
tradit
chines
herbal
medicin
play
import
role
treatment
sar
confirm
case
receiv
tradit
chines
herbal
medicin
cochran
review
found
chines
herb
combin
western
medicin
significantli
improv
symptom
sar
includ
decreas
bodi
temperatur
cough
breath
difficulti
dosag
corticosteroid
improv
absorpt
pulmonari
infiltr
qualiti
life
review
studi
tradit
chines
herbal
medicin
sar
reveal
posit
inconclus
result
efficaci
combin
treatment
use
tradit
chines
herbal
medicin
adjuv
base
previou
experi
treat
sar
tradit
chines
herbal
medicin
gener
offic
nation
health
health
commiss
china
offic
state
administr
tradit
chines
medicin
encourag
integr
tradit
chines
herbal
medicin
western
medicin
differ
prescript
recommend
differ
stage
diseas
first
systemat
review
examin
empir
evid
applic
tradit
chines
herbal
medicin
pneumonia
provid
overview
applic
tradit
chines
herbal
medicin
treat
patient
assess
strength
limit
avail
evid
furthermor
guid
prisma
statement
measur
tool
assess
systemat
review
amstar
checklist
achiev
high
level
qualiti
possibl
report
methodolog
protocol
may
limit
develop
base
design
current
regist
clinic
trial
updat
propos
method
promptli
prospero
record
method
chang
review
help
explor
potenti
role
tradit
chines
herbal
medicin
treatment
prevent
viral
infect
affect
pneumonia
